The FDA has recently issued major updates to the Emergency Use Authorizations (EUA) for bamlanivimab and etesevimab administered together and REGEN-COV, both authorized for the treatment of mild to moderate COVID-19 in eligible patients. Please see the most recent FDA Fact Sheet (bamlanivimab and etesevimab) for Healthcare Providers.
Breaking News:
JOIN THE FIGHT
Find ways to prevent, treat or help fight COVID-19.
WE NEED PEOPLE LIKE YOU
LEARN HOW YOU CAN HELP
I’VE NEVER HAD COVID-19
Healthy people can help in the fight against the pandemic by volunteering for a clinical trial to find safe and effective new vaccines.
I HAD COVID-19 AND RECOVERED
People who have recovered can help in the fight against COVID-19 by donating plasma that can be used to treat hospitalized patients, especially those who have severe cases of the disease.
I HAVE COVID-19 NOW
People with the disease can help in the fight against COVID-19 by participating in a clinical trial to develop effective ways to treat the disease.
Find a monoclonal antibody treatment infusion center location near you.
HOW DO VACCINES WORK?
Simply put, a vaccine trains the immune system to recognize viruses, bacteria, and other germs, or pathogens, so the body can react. The human body produces special proteins called antibodies to fight germs like the virus that causes COVID-19. Vaccines introduce weakened or killed parts of pathogens, or elements that mimic their structure, into the body.
COVID-19 vaccines cause your body to safely develop antibodies that recognize and fight the coronavirus that causes the disease, greatly reducing the risk for full-scale infection.
Do you have COVID-19 and are at high risk of severe symptoms? There's a treatment option that may help.
Where Can You Donate Plasma?
There are many options for donating convalescent plasma for the treatment of hospitalized, critically ill COVID-19 patients. If you have recovered from COVID-19, you can help others recover.
Donate PlasmaIf you are a healthcare provider treating hospitalized COVID-19 patients, consider talking to your patients about inpatient treatment trials.